CD33 and breast carcinoma: In breast cancer tissues, many reports have described, with various degree of accuracy, myeloid cells exhibiting an immature phenotype (CD33+CD13+CD14-CD15-) and immunosuppressive properties, which have been associated with adverse prognostic features (higher tumor grade, positive lymph nodes) (63).